These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6992903)

  • 21. A clinical overview of monoamine oxidase inhibitors.
    Zisook S
    Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of combined antidepressant therapy in resistant neurotic disorder.
    Tyrer P; Murphy S
    Br J Psychiatry; 1990 Jan; 156():115-8. PubMed ID: 2404536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive classification and prediction of response to phenelzine.
    Paykel ES; Parker RR; Penrose RJ; Rassaby ER
    Br J Psychiatry; 1979 Jun; 134():572-81. PubMed ID: 476367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptomatic treatment of agoraphobia and social phobias: a follow-up study.
    Tyrer P; Steinberg D
    Br J Psychiatry; 1975 Aug; 127():163-8. PubMed ID: 241454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenelzine efficacy in refractory social anxiety disorder: a case series.
    Aarre TF
    Nord J Psychiatry; 2003; 57(4):313-5. PubMed ID: 12888407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
    Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
    Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 29. Phenelzine in phobic states.
    Kelly D
    Proc R Soc Med; 1973 Sep; 66(9):949-50. PubMed ID: 4156084
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol.
    Liebowitz MR; Gorman JM; Fyer AJ; Campeas R; Levin AP; Sandberg D; Hollander E; Papp L; Goetz D
    J Clin Psychiatry; 1988 Jul; 49(7):252-7. PubMed ID: 3292516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenelzine in phobic anxiety: a controlled trial.
    Tyrer P; Candy J; Kelly D
    Psychol Med; 1973 Feb; 3(1):120-4. PubMed ID: 4571145
    [No Abstract]   [Full Text] [Related]  

  • 32. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
    Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
    J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 36. A double blind trial of phenelzine and amitriptyline in depressed out-patients.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1974 Feb; 124(579):219. PubMed ID: 4596674
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.
    Johnstone EC
    Psychopharmacologia; 1976 Apr; 46(3):289-94. PubMed ID: 951464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sertraline in social phobia.
    Van Ameringen M; Mancini C; Streiner D
    J Affect Disord; 1994 Jun; 31(2):141-5. PubMed ID: 8071477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.